Roche will invest $550 million in Indianapolis for a new manufacturing facility for glucose monitoring devices, adding ...

Long-term clinical evaluation represents key advancement following successful first-in-human studyRUTHERFORD, N.J., May 13, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or ...

Both Meal and Glucose are now available to Oura members on iOS and Android in the US. The company says international ...

Continuous glucose monitoring provides a new, less invasive method for evaluating diabetes risk. Fluctuations in blood ...

Continuous glucose monitoring (CGM) devices may overestimate blood glucose levels in healthy adults, potentially leading to unnecessary dietary changes and confusion among users, according to a ...

Enhanced by remote monitoring, telemedicine, and wearable devices, this market is booming across North America and Asia Pacific. Blood glucose monitoring dominates, while cardiac devices are rapidly ...

Roche Diagnostics plans to produce glucose monitors at the site within three years and prepare for future generations of its ...

Future Market Insights (FMI) has revealed an insightful new report showcasing the remarkable growth trajectory of the global patient monitoring devices market. Valued at USD 46.4 million in 2022, the ...

I wore Dexcom’s over-the-counter blood glucose monitor for a month. Here’s how it compares to Lingo and what it’s like to use ...

Roche said Monday it plans to invest up to $550 million and add hundreds of jobs over the next five years at its Indianapolis ...

A continuous glucose monitor (CGM) is a small wearable device that sends blood sugar measurements directly to your smartphone or to a dedicated receiver device every few minutes. It offers people ...